Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has reached an agreement regarding the sale of the business unit Thermoplastic Elastomers (Sarlink@), part of the business group DSM Elastomers, to Teknor Apex Company (Teknor Apex). The intended sale is expected to close in Q4 2010, subject to regulatory and other customary approvals and notifications.
The intended sale of the business unit is a result of DSM's ambitions to focus on Life Sciences and Materials Sciences. As announced in September 2007, DSM Elastomers (Sarlink@ and Keltan@) does not fit with this focus.
Both parties have agreed not to disclose financial details at this time. DSM expects to report a small book profit as a result of the transaction upon closing. Approximately 90 employees will transfer to the new owner upon closing.
Sarlink@ has compounding operations in Leominster (Massachusetts, United States) and Genk (Belgium). While the business unit will operate as an integral part of Teknor Apex, it will continue to sell its TPVs (thermoplastic vulcanizate) under the Sarlink@ name. In 2009 Sarlink@ realized net sales of over EUR 50 million.
Nico Gerardu, Member of the DSM Managing Board and responsible for the Base Chemicals and Materials cluster, commented: "The sale of Sarlink@ is another important step for DSM in its ongoing transformation towards a Life Sciences and Materials Sciences company. As there is a natural fit with Teknor Apex, we see a bright future ahead for Sarlink@ under new ownership. I would like to thank all Sarlink@ employees for their ongoing support and substantial contribution to DSM."
Bertram M. Lederer, executive vide president of Teknor Apex said: "Teknor Apex is a good home for the Sarlink@ group, and the enhanced potential from our combined people and resources will benefit customers. The addition of the Sarlink@ TPV business strengthens the position of Teknor Apex as the world's most diversified independent compounder of TPEs and expands our portfolio at the high-performance end, particularly for automotive applications."
Sarlink@ is one of the two business units of the business group DSM Elastomers. The selling process for Keltan@ (EPDM), the other business unit of DSM Elastomers, as well as most of the remaining other businesses in Base Chemicals and Materials is ongoing.
Teknor Apex Company
A privately held firm founded in 1924. Teknor Apex Company is an international polymer technology company and one of the world's leading custom compounders of plastics. For U.S. markets, the company also manufactures chemicals such as plasticizers and the nationally branded consumer product, Apex@ garden hose. Teknor Apex is headquartered in Pawtucket, RI, U.S.A., operates manufacturing facilities around the world, and sells in 90 countries. Six of the eight Teknor Apex business units focus on plastics compounding, including bioplastics; color concentrates; nylon, PET, and other engineering thermoplastics; thermoplastic elastomers; toll and specialty compounds; and vinyl. The company's operations in the U.S. serve customers throughout the Americas. Subsidiaries in China, Singapore, and the United Kingdom serve customers in Asia, Africa, the Mideast, and Europe. Visit www.teknorapex.com (http://www.teknorapex.com) .
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, withlocations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com (http://www.dsm.com)
For more information: DSM Corporate Communications DSM Investor Relations Herman Betten Hans Vossen tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864 fax +31 (0) 45 5740680 fax +31 (0) 10 4590275 e-mail email@example.com (mailto:firstname.lastname@example.org) e-mail email@example.com (mailto:firstname.lastname@example.org)
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE